Besides, silencing TREM2 suppresses cell proliferation, invasion, and migration and significantly increases the apoptosis of glioma cell lines, suggesting that TREM2 may be a novel therapeutic target 19. The gene discussed is TREM2; the disease is central nervous system cancer.